UK pharma major AstraZeneca (LSE: AZN) today revealed that its Calquence (acalabrutinib) in combination with bendamustine and ...

USA-based rare disease drug developer PTC Therapeutics (Nasdaq: PTCT) on Monday announced results from the Phase II PIVOT-HD ...

Portugal-based Hovione and Firstgene Life Sciences, a portfolio company of the Swiss incubator Xlife Sciences (SIX: XLS), ...

Benchtop cell factory company Astraveus has entered into a strategic partnership with The Netherlands Center for the Clinical ...

Priothera today announced the appointment of Jens Hasskarl, as its chief medical officer (CMO). Founded in France and ...

The US Food and Drug Administration (FDA) accepted Novo Nordisk’s New Drug Application (NDA) submission for an ...

US subsidiary and Iceland-based Alvotech (Nasdaq: ALVO) today announced that the US Food and Drug Administration (FDA) has ...

German biotech BioNTech (Nasdaq: BNTX) saw its shares dip 3.4% to $101.44 today, after it reported financial results for the ...

T-cell immunotherapies (TCI) are redefining cancer care, with chimeric antigen receptor T-cell (CAR-T) therapies witnessing ...

In the USA, the Trump administration is urging congressional Republicans to include a “most favored nation” (MFN) policy in ...

The introduction of outpatient flat-rate payments approved today by the Swiss Federal Council poses significant risks for ...

Sweden’s Mendus (STO: IMMU), a clinical-stage drug developer, has announced the appointment of Dr Tariq Mughal as chief ...